Lotus Pharmaceutical Co., Ltd. (1795)
TWSE
Closed
Aug 26, 2026
Day's Range
193.0052 wk Range
170.50Overview - 1795 - Lotus Pharmaceutical Co., Ltd.
Key Statistics
Valuation
Enterprise Value
104.30B
P/E (Trailing)
‪13.48‬
P/E (Forward)
‪7.69‬
PEG Ratio
‪-0.22‬
Price / Sales (TTM)
‪1.78‬
Price / Book
‪2.12‬
EV / EBITDA
‪11.33‬
Profitability
Gross Margin
‪50.73%‬
Profit Margin
‪13.22%‬
Operating Margin
‪26.48%‬
Return on Assets
‪6.20%‬
Return on Equity
‪16.86%‬
Ownership
Shares Outstanding
262.80M
Float
135.42M
Held by Insiders
‪48.60%‬
Held by Institutions
‪10.68%‬
Price stats
Beta
‪0.64‬
50-Day Avg
‪190.93‬
200-Day Avg
‪244.05‬
Dividends
Payout Ratio
‪40.15%‬
Analyst Consensus
4 analysts
Market Cap - 1795 - Lotus Pharmaceutical Co., Ltd.
Peers - 1795 - Lotus Pharmaceutical Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.
Profile Summary - 1795 - Lotus Pharmaceutical Co., Ltd.
About
Lotus Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacture, and sale of a wide range of healthcare products. Its primary function is to produce generic and specialty pharmaceuticals that cater to the healthcare needs across various therapeutic areas. Lotus Pharmaceutical focuses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
